Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest

Jennifer W-M Gho1, Wai-Ki Ip, Kathy Y-Y Chan

  • 1Li Ka-Shing Institute of Health Sciences, Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong, China.

Cancer Research
|August 15, 2008
PubMed

Insights

Down-regulation of the transcription factor ATF5 is common in hepatocellular carcinoma (HCC), inhibiting tumor growth and causing cell cycle arrest. ID1 is identified as a downstream target, suggesting ATF5 acts as a tumor suppressor in HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Transcription factors regulate crucial cellular processes like proliferation and cell cycle.
  • Hepatocellular carcinoma (HCC) is a malignant tumor with poor prognosis.
  • ATF5 (Activating Transcription Factor 5) is a transcription factor implicated in various cellular functions.

Purpose of the Study:

  • To investigate the role of ATF5 in hepatocellular carcinoma (HCC).
  • To identify downstream targets and regulatory mechanisms of ATF5 in HCC.
  • To explore ATF5 as a potential therapeutic target for HCC.

Main Methods:

  • Array-based mapping and quantitative reverse transcription-PCR to assess ATF5 expression in HCC tumors and adjacent non-tumoral liver.
  • Restoration of ATF5 expression in HCC cell lines to evaluate its effect on proliferation, apoptosis, and cell cycle.
  • Array profiling to identify differentially expressed genes and electromobility shift assays to confirm ATF5-ID1 interaction.
  • Analysis of potential mechanisms for ATF5 silencing, including copy number loss, promoter hypermethylation, histone deacetylation, and DNA mutations.

Main Results:

  • Consistent down-regulation of ATF5 was observed in 78% of HCC tumors compared to non-tumoral liver tissue.
  • Restoring ATF5 expression in HCC cell lines significantly inhibited growth and induced G2-M cell cycle arrest.
  • ID1 was identified as a downstream target of ATF5, with an inverse expression relationship and direct promoter interaction.
  • Mechanisms contributing to ATF5 silencing in HCC include copy number losses, promoter hypermethylation, histone deacetylation, and DNA mutations.

Conclusions:

  • ATF5 plays a tumor-suppressive role in hepatocellular carcinoma.
  • ID1 is a key downstream target regulated by ATF5 in HCC.
  • Understanding ATF5 regulation and function provides insights into HCC pathogenesis and potential therapeutic strategies.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...